An estimated 1 in 10 U.S. adults had overlapping heavy drinking and obesity conditions in 2023, a cross-sectional study found ...

As medical organizations, lawmakers, advocates -- and even the lead actor from "The Pitt" -- laud the reauthorization of the ...

The FDA approved islatravir-doravirine (Idvynso) as a standalone, single-tablet regimen for treating HIV in virologically ...

"Parents don't immunize their children or give them other routine care, and then the kids get sick and they might even die," ...

Conventional wisdom holds that nonsteroidal anti-inflammatory drugs (NSAIDs) can trigger disease flares in patients with ...

Treatment with investigational elisrasib, a next-generation KRAS G12C inhibitor, showed efficacy in patients with advanced ...

The Trump administration will require all 50 states to explain their plans to revalidate some of their Medicaid providers in ...

The C-reactive protein-triglyceride-glucose index may be a useful biomarker for identifying individuals at elevated risk of ...

Real-world data suggested the dual GLP-1/GIP receptor agonist tirzepatide (Mounjaro, Zepbound) was associated with greater ...

Adjunctive corticosteroid therapy accelerated resolution of hypoxemia in hospitalized adults with Mycoplasma pneumoniae ...

Zasocitinib, which is a potent and highly selective TYK2 inhibitor would be a good option for some of our patients who are ...